The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Paraoxonase and Atherosclerosis
Abstract
Abstract—There is considerable evidence that the antioxidant activity of high density lipoprotein (HDL) is largely due to the paraoxonase-1 (PON1) located on it. Experiments with transgenic PON1 knockout mice indicate the potential for PON1 to protect against atherogenesis. This protective effect of HDL against low density lipoprotein (LDL) lipid peroxidation is maintained longer than is the protective effect of antioxidant vitamins and could thus be more important. There is evidence that the genetic polymorphisms of PON1 least able to protect LDL against lipid peroxidation are overrepresented in coronary heart disease, particularly in association with diabetes. However, these polymorphisms explain only part of the variation in serum PON1 activity; thus, a more critical test of the hypothesis is likely to be whether low serum PON1 activity is associated with coronary heart disease. Preliminary case-control evidence suggests that this is indeed the case and, thus, that the quest for dietary and pharmacological means of modifying serum PON1 activity may allow the oxidant model of atherosclerosis to be tested in clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of oxidized low density lipoprotein in atherogenesis.
Witztum, J. L., & Steinberg, D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115499 · Cited by 2,675
Vitamin E Supplementation and Cardiovascular Events in High-Risk Patients
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420302 · Cited by 1,957
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
Brooks-Wilson, A., Marcil, M., Clee, S. M., Zhang, L.-H., Roomp, K., van Dam, M., Yu, L., Brewer, C., Collins, J. A., Molhuizen, H. O. F., et al. (1999) · Nature Genetics · doi:10.1038/11905 · Cited by 1,687
The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
Bodzioch, M., Orsó, E., Klucken, J., Langmann, T., Böttcher, A., Diederich, W., Drobnik, W., Barlage, S., Büchler, C., Porsch-Özcürümez, M., et al. (1999) · Nature Genetics · doi:10.1038/11914 · Cited by 1,512
Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1
Rust, S., Rosier, M., Funke, H., Real, J., Amoura, Z., Piette, J.-C., Deleuze, J.-F., Brewer, H. B., Duverger, N., Denèfle, P., et al. (1999) · Nature Genetics · doi:10.1038/11921 · Cited by 1,433
Aviram, M., Rosenblat, M., Bisgaier, C. L., Newton, R. S., Primo-Parmo, S. L., & La Du, B. N. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1649 · Cited by 1,168
Watson, A. D., Berliner, J. A., Hama, S. Y., La Du, B. N., Faull, K. F., Fogelman, A. M., & Navab, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118359 · Cited by 1,154
Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis
Shih, D. M., Gu, L., Xia, Y.-R., Navab, M., Li, W.-F., Hama, S., Castellani, L. W., Furlong, C. E., Costa, L. G., Fogelman, A. M., et al. (1998) · Nature · doi:10.1038/28406 · Cited by 1,078
Paraoxonase prevents accumulation of lipoperoxides in low‐density lipoprotein
Mackness, M. I., Arrol, S., & Durrington, P. N. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80962-3 · Cited by 977
Self-citationClinical features of sudden obstruction of the coronary arteries
HERRICK, J. B. (1912) · Journal of the American Medical Association · doi:10.1001/jama.1912.04270120001001 · Cited by 908
Van Lenten, B. J., Hama, S. Y., de Beer, F. C., Stafforini, D. M., McIntyre, T. M., Prescott, S. M., La Du, B. N., Fogelman, A. M., & Navab, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118345 · Cited by 840
High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein
Parthasarathy, S., Barnett, J., & Fong, L. G. (1990) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(90)90314-n · Cited by 827
MACKNESS, M., ARROL, S., ABBOTT, C., & DURRINGTON, P. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90183-u · Cited by 816
Self-citationBadimon, J. J., Badimon, L., & Fuster, V (1990) · Journal of Clinical Investigation · doi:10.1172/jci114558 · Cited by 764
Navab, M., Imes, S. S., Hama, S. Y., Hough, G. P., Ross, L. A., Bork, R. W., Valente, A. J., Berliner, J. A., Drinkwater, D. C., & Laks, H. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115532 · Cited by 737
Lawn, R. M., Wade, D. P., Garvin, M. R., Wang, X., Schwartz, K., Porter, J. G., Seilhamer, J. J., Vaughan, A. M., & Oram, J. F. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8119 · Cited by 724
The Human Serum Paraoxonase/Arylesterase Gene (PON1) Is One Member of a Multigene Family
Primo-Parmo, S. L., Sorenson, R. C., Teiber, J., & Du, B. N. L. (1996) · Genomics · doi:10.1006/geno.1996.0225 · Cited by 673
The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin
Davies, H. G., Richter, R. J., Keifer, M., Broomfield, C. A., Sowalla, J., & Furlong, C. E. (1996) · Nature Genetics · doi:10.1038/ng1196-334 · Cited by 603
Chait, A., Brazg, R. L., Tribble, D. L., & Krauss, R. M. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90144-e · Cited by 554
Hayek, T., Fuhrman, B., Vaya, J., Rosenblat, M., Belinky, P., Coleman, R., Elis, A., & Aviram, M. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.11.2744 · Cited by 552
A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits
Okamoto, H., Yonemori, F., Wakitani, K., Minowa, T., Maeda, K., & Shinkai, H. (2000) · Nature · doi:10.1038/35018119 · Cited by 531
Griffin, B. A., Freeman, D. J., Tait, G. W., Thomson, J., Caslake, M. J., Packard, C. J., & Shepherd, J. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90129-5 · Cited by 525
Hessler, J. R., Robertson, A. L., & Chisolm, G. M. (1979) · Atherosclerosis · doi:10.1016/0021-9150(79)90166-7 · Cited by 505
Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus
Mackness, M. I., Harty, D., Bhatnagar, D., Winocour, P. H., Arrol, S., Ishola, M., & Durrington, P. N. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90215-o · Cited by 492
Self-citationAdkins, S., Gan, K., Mody, M., & Du, B. N. L. (1993) · PubMed · Cited by 478
Garin, M. C., James, R. W., Dussoix, P., Blanché, H., Passa, P., Froguel, P., & Ruiz, J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119134 · Cited by 476
Aviram, M., Hardak, E., Vaya, J., Mahmood, S., Milo, S., Hoffman, A., Billicke, S., Draganov, D., & Rosenblat, M. (2000) · Circulation · doi:10.1161/01.cir.101.21.2510 · Cited by 460
Aviram, M., Billecke, S., Sorenson, R., Bisgaier, C., Newton, R., Rosenblat, M., Erogul, J., Hsu, C., Dunlop, C., & La Du, B. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.10.1617 · Cited by 458
Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins
Mackness, M. I., Mackness, B., Durrington, P. N., Connelly, P. W., & Hegele, R. A. (1996) · Current Opinion in Lipidology · doi:10.1097/00041433-199604000-00004 · Cited by 447
Self-citationHDL, its enzymes and its potential to influence lipid peroxidation
Mackness, M. I., & Durrington, P. N. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05524-m · Cited by 418
Self-citationHuman Serum Paraoxonase (pon1) Isozymes Q and R Hydrolyze Lactones and Cyclic Carbonate Esters
Billecke, S., Draganov, D., Counsell, R., Stetson, P., Watson, C., Hsu, C., & Du, B. N. L. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15082-9 · Cited by 402
Calcium-dependent Human Serum Homocysteine Thiolactone Hydrolase
Jakubowski, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.3957 · Cited by 398
Abbott, C. A., Mackness, M. I., Kumar, S., Boulton, A. J., & Durrington, P. N. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.11.1812 · Cited by 387
Self-citationMackness, B., Mackness, M. I., Arrol, S., Turkie, W., & Durrington, P. N. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00064-7 · Cited by 377
Self-citationBLATTER, M., JAMES, R. W., MESSMER, S., BARJA, F., & POMETTA, D. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17620.x · Cited by 347
Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes
Ruiz, J., Morabia, A., Blanche, H., James, R. W., Garin, M.-C. B., Charpentier, G., Passa, P., Vaisse, C., Ruiz, J., & Froguel, P. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92709-3 · Cited by 344
Serrato, M., & Marian, A. J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118373 · Cited by 339
Draganov, D. I., Stetson, P. L., Watson, C. E., Billecke, S. S., & La Du, B. N. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004543200 · Cited by 338
Leviev, I., & James, R. W. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.2.516 · Cited by 308
Mackness, M. I., Abbott, C., Arrol, S., & Durrington, P. N. (1993) · Biochemical Journal · doi:10.1042/bj2940829 · Cited by 305
Self-citationAviram, M., Rosenblat, M., Bisgaier, C. L., & Newton, R. S. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00032-x · Cited by 296
Steinbrecher, U. P., Lougheed, M., Kwan, W. C., & Dirks, M. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84812-3 · Cited by 289
Pharmacogenetics of drug metabolism
Kalow, W. (1980) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(80)90063-2 · Cited by 289
Serum Paraoxonase After Myocardial Infarction
Ayub, A., Mackness, M. I., Arrol, S., Mackness, B., Patel, J., & Durrington, P. N. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.2.330 · Cited by 287
Self-citationRemaley, A. T., Rust, S., Rosier, M., Knapper, C., Naudin, L., Broccardo, C., Peterson, K. M., Koch, C., Arnould, I., Prades, C., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12685 · Cited by 269
Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response
Feingold, K. R., Memon, R. A., Moser, A. H., & Grunfeld, C. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00084-7 · Cited by 248
Distribution of paraoxon hydrolytic activity in the serum of patients after myocardial infarction.
McElveen, J. E., Mackness, M., COLLEY, C. M., Peard, T., Warner, S., & Walker, C. H. (1986) · Clinical Chemistry · doi:10.1093/clinchem/32.4.671 · Cited by 227
Self-citationDuverger, N., Kruth, H., Emmanuel, F., Caillaud, J.-M., Viglietta, C., Castro, G., Tailleux, A., Fievet, C., Fruchart, J. C., Houdebine, L. M., et al. (1996) · Circulation · doi:10.1161/01.cir.94.4.713 · Cited by 225
Tomás, M., Sentí, M., García-Faria, F., Vila, J., Torrents, A., Covas, M., & Marrugat, J. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.9.2113 · Cited by 223
Mackness, B., Mackness, M. I., Arrol, S., Turkie, W., & Durrington, P. N. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701390 · Cited by 211
Self-citationMackness, B., Hunt, R., Durrington, P. N., & Mackness, M. I. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.7.1233 · Cited by 210
Self-citationHaley, R. W., Billecke, S., & La Du, B. N. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8703 · Cited by 204
van der Gaag, M. S., van Tol, A., Scheek, L. M., James, R. W., Urgert, R., Schaafsma, G., & Hendriks, H. F. J. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00243-9 · Cited by 197
Rowles, J., Scherer, S. W., Xi, T., Majer, M., Nickle, D. C., Rommens, J. M., Popov, K. M., Harris, R. A., Riebow, N. L., Xia, J., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.37.22376 · Cited by 191
The Biology of Cholesterol and Related Steroids
(1981) · Elsevier eBooks · doi:10.1016/c2013-0-11801-6 · Cited by 190
Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice.
Li, H., Reddick, R. L., & Maeda, N. (1993) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.13.12.1814 · Cited by 189
Decrease of serum paraoxonase activity in chronic renal failure.
Dantoine, T. F., Debord, J., Charmes, J. P., Merle, L., Marquet, P., Lachatre, G., & Leroux-Robert, C. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v9112082 · Cited by 188
Apolipoprotein J Is Associated with Paraoxonase in Human Plasma
Kelso, G. J., Stuart, W. D., Richter, R. J., Furlong, C. E., Jordan-Starck, T. C., & Harmony, J. A. K. (1994) · Biochemistry · doi:10.1021/bi00169a026 · Cited by 179
Mackness, M., Arrol, S., Mackness, B., & Durrington, P. N. (1997) · The Lancet · doi:10.1016/s0140-6736(05)61755-2 · Cited by 173
Self-citationOdawara, M., Tachi, Y., & Yamashita, K. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.7.2257 · Cited by 156
Ikeda, Y., Suehiro, T., Inoue, M., Nakauchi, Y., Morita, T., Arii, K., Ito, H., Kumon, Y., & Hashimoto, K. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90246-3 · Cited by 153
Reduced Postprandial Serum Paraoxonase Activity After a Meal Rich in Used Cooking Fat
Sutherland, W. H. F., Walker, R. J., de Jong, S. A., van Rij, A. M., Phillips, V., & Walker, H. L. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.5.1340 · Cited by 153
Durrington, P. N., Mackness, M., Bhatnagar, D., Julier, K., Prais, H., Arrol, S., Morgan, J., & Wood, G. N. I. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00003-3 · Cited by 145
Self-citationHydrolysis of platelet-activating factor by human serum paraoxonase
Rodrigo, L. S., Mackness, B., Durrington, P. N., Hernández, A. F., & Mackness, M. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3540001 · Cited by 138
Self-citationStructural and functional diversity of paraoxonases
Du, B. N. L. (1996) · Nature Medicine · doi:10.1038/nm1196-1186 · Cited by 137
Pfohl, M., Koch, M., Enderle, M., Kühn, R., Füllhase, J., Karsch, K. R., & Häring, H.-U. (1999) · Diabetes · doi:10.2337/diabetes.48.3.623 · Cited by 125
Brain Abnormalities in Gulf War Syndrome: Evaluation with1H MR Spectroscopy
Haley, R. W., Marshall, W. W., McDonald, G., Daugherty, M. A., Petty, F., & Fleckenstein, J. L. (2000) · Radiology · doi:10.1148/radiology.215.3.r00jn48807 · Cited by 109
Hydrolysis of platelet-activating factor by human serum paraoxonase
Rodrigo, L. S., Mackness, B., Durrington, P. N., Hernández, A. F., & Mackness, M. (2001) · Biochemical Journal · doi:10.1042/bj3540001 · Cited by 96
Self-citationGenetic polymorphism of paraoxonase 1 (PON1) and susceptibility to Parkinson's disease
Kondo, I., & Yamamoto, M. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00586-1 · Cited by 91
Hedrick, C. C., Hassan, K., Hough, G. P., Yoo, J., Simzar, S., Quinto, C. R., Kim, S.-M., Dooley, A. N., Langi, S., Hama, S. Y., et al. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.8.1946 · Cited by 89
Graham, A., Hassall, D. G., Rafique, S., & Owen, J. S. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00162-7 · Cited by 88
Hegele, R. A., Connelly, P. W., Scherer, S. W., et al. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.10.4289 · Cited by 85
Apolipoprotein J: a membrane policeman?
Jordan, T. C., Witte, D. P., Aronow, B. J., & Harmony, J. A. K. (1992) · Current Opinion in Lipidology · doi:10.1097/00041433-199204000-00004 · Cited by 85
Schmidt, R., Schmidt, H., Fazekas, F., Kapeller, P., Roob, G., Lechner, A., Kostner, G. M., & Hartung, H. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.7.1811 · Cited by 80
Paraoxonase Activity Is Reduced by a Pro-atherosclerotic Diet in Rabbits
Mackness, M., Bouiller, A., Hennuyer, N., Mackness, B., Hall, M., Tailleux, A., Duriez, P., Delfly, B., Durrington, P. N., Fruchart, J., et al. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2265 · Cited by 79
Self-citationLow Paraoxonase in Persian Gulf War Veterans Self-Reporting Gulf War Syndrome
Mackness, B., Durrington, P. N., & Mackness, M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3526 · Cited by 79
Self-citationGrundy, S. M., Vega, G. L., Otvos, J. D., Rainwater, D. L., & Cohen, J. C. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33361-7 · Cited by 72
Reverse Cholesterol Transport and Atherosclerosis Regression
Spady, D. K. (1999) · Circulation · doi:10.1161/01.cir.100.6.576 · Cited by 69
James, R. W., Blatter, M.-C., Calabresi, L., Miccoli, R., von Eckardstein, A., Tilly-Kiesi, M., Taskinen, M., Assmann, G., & Franceschini, G. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00058-6 · Cited by 66
Structural Organization of the HumanPON1Gene
Clendenning, J. B., Humbert, R., Green, E. D., Wood, C. M., Traver, D. J., & Furlong, C. E. (1996) · Genomics · doi:10.1006/geno.1996.0401 · Cited by 63
Low A-esterase activity in serum of patients with fish-eye disease.
Mackness, M., Walker, C. H., & Carlson, L. A. (1987) · Clinical Chemistry · doi:10.1093/clinchem/33.4.587 · Cited by 61
Self-citationCholesteryl ester transfer protein and atherosclerosis
Inazu, A., Koizumi, J., & Mabuchi, H. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200008000-00008 · Cited by 58
Arrol, S., Mackness, M., & Durrington, P. N. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00353-6 · Cited by 53
Self-citationLack of Protection against Oxidative Modification of LDL by Avian HDL
Mackness, B., Durrington, P. N., & Mackness, M. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8803 · Cited by 51
Self-citationBhatnagar, D., Durrington, P. N., Mackness, M., Arrol, S., Winocour, P. H., & Prais, H. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90009-6 · Cited by 47
Self-citationAbsence of “A”-esterase activity in the serum of a patient with tangier disease
Mackness, M. I., Peuchant, E., Dumon, M., et al. (1989) · Clinical Biochemistry · doi:10.1016/s0009-9120(89)80101-8 · Cited by 37
Self-citationParagh, G., Balogh, Z., Seres, I., Harangi, M., Boda, J., & Kovacs, P. L. (2000) · Clinical Drug Investigation · doi:10.2165/00044011-200019040-00005 · Cited by 30
Cholesterol and Atherosclerosis
Myant, N. (1981) · Elsevier eBooks · doi:10.1016/b978-0-433-22880-6.50020-5 · Cited by 2
Cited by
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
Forrester, S. J., Kikuchi, D. S., Hernandes, M. S., Xu, Q., & Griendling, K. K. (2018) · Circulation Research · doi:10.1161/circresaha.117.311401 · Cited by 2,081
Antiinflammatory Properties of HDL
Barter, P. J., Nicholls, S., Rye, K.-A., Anantharamaiah, G. M., Navab, M., & Fogelman, A. M. (2004) · Circulation Research · doi:10.1161/01.res.0000146094.59640.13 · Cited by 1,394
Draganov, D. I., Teiber, J. F., Speelman, A., Osawa, Y., Sunahara, R., & La Du, B. N. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400511-jlr200 · Cited by 715
Bhattacharyya, T. (2008) · JAMA · doi:10.1001/jama.299.11.1265 · Cited by 533
Hansel, B., Giral, P., Nobecourt, E., Chantepie, S., Bruckert, E., Chapman, M. J., & Kontush, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0305 · Cited by 477
Metadata
- Authors
- Durrington, P. N., Mackness, B., & Mackness, M. I.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2001-04
- Volume
- 21
- Issue
- 4
- Pages
- 473-480
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2084075677
- Cited by
- 818
- References
- 88
- FWCI
- 24.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.